Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context

Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data

(2013) Nicholas R. Latimer   MEDICAL DECISION MAKING

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

(2012) Patricia Guyot et al.   BMC Medical Research Methodology

Incorporating prognostic factors into causal estimators: A comparison of methods for randomised controlled trials with a time-to-event outcome

(2012) Lisa V. Hampson et al.   STATISTICS IN MEDICINE

Limitation of Inverse Probability-of-Censoring Weights in Estimating Survival in the Presence of Strong Selection Bias

(2011) Chanelle J. Howe et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study

(2011) James P Morden et al.   BMC Medical Research Methodology

Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness

(2011) Patricia Guyot et al.   VALUE IN HEALTH

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

(2008) Jan B. Vermorken et al.   NEW ENGLAND JOURNAL OF MEDICINE